Autopsy report · NCT00058188

Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation

“Closed by the research committee”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 5 years 8 months before it stopped.
• 53 participants enrolled.
• Results were posted on the registry 12 years after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Northwestern University

Sponsor type

University, hospital or other

Conditions

Osteoporosis; Prostate Cancer

Interventions

cholecalciferol; calcium gluconate; zoledronic acid

Participants

53

Sites

3

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.